DPBA | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

DPBA
FDA Orange Book

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

pharmacompass-1-m-2026-01-12

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Together we can improve the quality of life

Contact Supplier

pharmacompass-2-m-2025-11-03

DPBA

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

80 API Suppliers, 26 USDMF, 6 JDMF, 14 EU WC, 13 KDMF, 23 NDC API, 44 Listed Suppliers, $ API Reference Price

80 API Suppliers
26 USDMF
6 JDMF
14 EU WC
13 KDMF
23 NDC API
44 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

144 Drugs in Development

144 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

252 FDF Dossiers, 33 FDA Orange Book, 124 Europe, 13 Canada, 26 Australia, 19 South Africa, 37 Listed Dossiers

252 FDF Dossiers
33 FDA Orange Book
124 Europe
13 Canada
26 Australia
19 South Africa
37 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 13 SPI Pharma, 1 DKSH, 1 Gangwal Healthcare, 1 Pfanstiehl, 1 Kirsch Pharma, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Evonik
1 Rochem International Inc
13 SPI Pharma
1 DKSH
1 Gangwal Healthcare
1 Pfanstiehl
1 Kirsch Pharma
1 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
1 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 10 Direct Compression, 10 Taste Masking, 8 Disintegrants & Superdisintegrants, 5 Parenteral, 3 Co-Processed Excipients, 3 Granulation, 2 Topical, 1 Solubilizers, 1 Thickeners and Stabilizers

17 Fillers, Diluents & Binders
12 Chewable & Orodispersible Aids
10 Direct Compression
10 Taste Masking
8 Disintegrants & Superdisintegrants
5 Parenteral
3 Co-Processed Excipients
3 Granulation
2 Topical
1 Solubilizers
1 Thickeners and Stabilizers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 154 News #PharmaBuzz

2 Data Compilation #PharmaFlow
154 News #PharmaBuzz

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 1 Regulatory FDF Prices, 15 Annual Reports

15 US Medicaid Prescriptions
1 Regulatory FDF Prices
15 Annual Reports

MARKET PLACE

7 APIs, 10 FDF Dossiers

7 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

11 US Patents

11 US Patents

REF. STANDARDS & IMPURITIES

3 USP, 8 Others

3 USP
8 Others

$ API Ref.Price (USD/KG) : 1,074,510 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

35 All

01 2DR REDDYS

02 3ACCORD HLTHCARE

03 2ACTAVIS LLC

04 1APOTEX

05 1BAXTER HLTHCARE CORP

06 1EUGIA PHARMA

07 2FRESENIUS KABI USA

08 2GLAND

09 1HETERO LABS LTD VI

10 3HOSPIRA

11 1JIANGSU HANSOH PHARM

12 2MAIA PHARMS INC

13 1MEITHEAL

14 1MSN

15 1PHARMASCIENCE INC

16 1PHARMOBEDIENT

17 1QILU PHARM HAINAN

18 1RELIANCE LIFE SCI

19 1SANDOZ

20 1SCINOPHARM TAIWAN

21 1SHILPA

22 1SHUANGCHENG

23 1TAKEDA PHARMS USA

24 1TEVA PHARMS USA

25 1VILIN BIO MED

26 1ZYDUS PHARMS

filter Dosage Reset all filters

35 All

01 2INJECTABLE; INJECTION

02 22INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

03 2POWDER;INTRAVENOUS

04 4POWDER;INTRAVENOUS, SUBCUTANEOUS

05 4SOLUTION;INTRAVENOUS

06 1SOLUTION;INTRAVENOUS, SUBCUTANEOUS

filter Regulatory Info Reset all filters

35 All

01 11DISCN

02 22RX

03 2Blank

filter Brand Name Reset all filters

35 All

01 34BORTEZOMIB

02 1VELCADE

filter RLD Reset all filters

35 All

01 25No

02 8Yes

03 2Blank

List of Suppliers

Product Main Page

01

DR REDDYS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Contact Supplier

Digital Content

RLD : No

TE Code : AP

Brand Name : BORTEZOMIB

Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2022-07-26

Application Number : 202963

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

Dr Reddy Company Banner

Product Web Link

Digital Content

02

DR REDDYS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Contact Supplier

Digital Content

RLD : No

TE Code :

Brand Name : BORTEZOMIB

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2019-10-04

Application Number : 206927

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

Product Web Link

Digital Content

03

ACCORD HLTHCARE

IPPE

Not Confirmed

ACCORD HLTHCARE

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

Brand Name : BORTEZOMIB

Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2022-07-26

Application Number : 204405

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

APOTEX

IPPE

Not Confirmed

APOTEX

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AP

Brand Name : BORTEZOMIB

Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2022-05-02

Application Number : 205533

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

FRESENIUS KABI USA

IPPE

Not Confirmed

FRESENIUS KABI USA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

Brand Name : BORTEZOMIB

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2017-11-06

Application Number : 205004

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

PHARMASCIENCE INC

IPPE

Not Confirmed

PHARMASCIENCE INC

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AP

Brand Name : BORTEZOMIB

Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2022-05-02

Application Number : 208392

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SANDOZ

IPPE

Not Confirmed

SANDOZ

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AP

Brand Name : BORTEZOMIB

Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2022-07-26

Application Number : 203654

RX/OTC/DISCN : RX

RLD : No

TE Code : AP

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

TAKEDA PHARMS USA

IPPE

Not Confirmed

TAKEDA PHARMS USA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AP

Brand Name : VELCADE

Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2003-05-13

Application Number : 21602

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AP

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

TEVA PHARMS USA

IPPE

Not Confirmed

TEVA PHARMS USA

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

Brand Name : BORTEZOMIB

Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2022-05-02

Application Number : 205857

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

PHARMOBEDIENT

Country

IPPE

Not Confirmed

PHARMOBEDIENT

Country

IPPE

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

RLD : No

TE Code :

Brand Name : BORTEZOMIB

Dosage Form : INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 3.5MG/VIAL

Approval Date : 2022-10-31

Application Number : 205160

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.